Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Now Debuting on the Tau Stage . . . The Dab1 Mutant Mouse
14 January 2003. Deficiencies in a component of the reelin developmental signaling cascade produces a mouse that mimics the increased phosphorylation of tau protein seen in Alzheimer's and other neurodegenerative tauopathies, according to a report in the current issue of the Journal of Neuroscience.

The "Tauists" have been less fortunate than the "Baptists" when it comes to animal models, but that has begun to change. In the past few years, there have been a number of reports of transgenic or mutant mouse models suitable for studying hyperphosphorylation and accumulation of tau protein (see ARF related news; ARF related news). These include the "reeler" strain of mice, in whom absence or mutation of the reelin gene interferes with cortical development to create ataxic mice that die young. This phenotype also appears when one interferes experimentally with proteins that interact with reelin, including two reelin receptors, ApoER2 and VLDLR, and the product of the gene Disabled1, or Dab1.

Jonathan Cooper and associates at the University of Texas Southwestern Medical Center in Dallas, Texas, have shown previously that interference with reelin or its two receptors causes tau hyperphosphorylation (Heisberger et al., 1999). In the current paper, they report the same for mice with either mutated or deleted Dab1 genes. This hyperphosphorylation appeared only in neurons of the hippocampus proper and the dentate gyrus, along with fiber tracts of the corpus callosum and the fasciculus retroflexus.

The genetic background played heavily into this. The same genetic manipulations caused tau hyperphosphorylation in Dab1 knockout and mutant mice on a background of the 129Sv x C57BL/6 (or SB) hybrid strain that is popular for generating knockout mice but not in the BALB/cByJ (or CC) strain. The survival effect also correlates with this difference: the SB Dab1-deficient mice die much earlier than the CC Dab1-deficient mice.

Quantitative trait locus analysis of the Dab1 knockout mice revealed one significant and three suggestive chromosomal loci that modulate tau phosphorylation. The significant locus on chromosome 16 is near the gene for APP, and one of the suggestive loci lies near the gene encoding PS-1 on chromosome 12. These proximities lead the authors to suggest the possibility that "polymorphisms in genes that cause neurodegeneration and tau hyperphosphorylation in humans also regulate tau hyperphosphorylation when reelin-Dab1 signaling is defective." Brich et al. stress that definitive proof of whether reelin and its associated proteins are active in regulating tau phosphorylation beyond the developmental period awaits the introduction of conditional knockout models-mice in which the activity of reelin, Dab1, and the receptors can be permitted long enough to allow normal development to take place before the gene activity is knocked out.-Hakon Heimer.

Reference:
Brich J, Shie F-S, Howell BW, Li R, Tus K, Wakeland Ek, Jin L-W, Mumby M, Churchill G, Herz J, Cooper JA. Genetic modulation of tau phosphorylation in the mouse. J Neurosci. 2003 Jan 1;23(1):187-92. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad